Researchers screened a library of drugs either FDA-approved or in clinical trial using a library of patient-derived H3K27M-mutant diffuse midline glioma cell lines with cell viability as the outcome.
[Neuro-Oncology]
Sorry, but the selected Zotpress account can't be found.
